Neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: Data from literature review and a real-world analysis.

Yao ZhangHuiting LiBo YuSi SunZhihuang HuXianghua WuYang ZhangBin LiYawei ZhangJiaqing XiangJialei WangHui Yu

Published in: Thoracic cancer (2024)

NCIT is safe and provides potential survival benefits for patients with locally advanced ESCC. However, randomized phase 3 trial data is still needed.

Keyphrases

locally advanced
rectal cancer
electronic health record
neoadjuvant chemotherapy
squamous cell carcinoma
big data
radiation therapy
open label
double blind
phase ii study
case report
lymph node
placebo controlled
randomized controlled trial
phase iii
risk assessment
deep learning